Educational protocol hub
IGF-1 LR3: protocol variants and reconstitution resources
Educational hub for IGF-1 LR3, grouping 2 available protocol variants with links to the exact dosage and reconstitution pages.
What this hub covers
This page groups the available IGF-1 LR3 protocol variants so readers can choose the exact vial-size guide without mixing formats.
Reconstitution workflow
Use the linked protocol pages and calculator resources to review concentration, diluent logic and unit conversions for the selected variant.
Research-only context
All information is educational and literature-focused. AllPeptides.eu does not sell peptides and does not provide medical advice.
Available protocol variants
Choose the exact guide you want to view.
IGF-1 LR3
IGF-1 LR3 (Long R3 Insulin-like Growth Factor-1) is a modified analog of human IGF-1 with a significantly extended half-life, studied for its anabolic and metabolic actions. This synthetic variant exhibits reduced binding to IGF binding proteins, allowing for enhanced bioavailability and systemic action. This protocol outlines a once-daily subcutaneous approach with conservative titration.
View protocolIGF-1 LR3
IGF-1 LR3 (Long R3 Insulin-like Growth Factor-1) is a modified analogue of human IGF-1 with a significantly prolonged half-life (~20–30 hours) due to reduced binding to IGFBPs. 2mg Vial — reconstitution with 2 mL of 0.6% acetic acid yields 1 mg/mL (1 unit = 10 mcg).
View protocolRelated research resources
Internal links that help readers and search engines understand this peptide topic cluster.
References
- Biomolecules (MDPI) — IGF-1 and its monitoring in medical diagnostics and sport
View Source - Dopinglinkki (FINCIS) — IGF-1 and LR3IGF-1: medical information and safety overview
View Source - Mayo Clinic / IBM Micromedex — Mecasermin (subcutaneous): proper use and timing with meals
View Source - Cell Sciences — Recombinant Human LR3 IGF-1: technical specifications for storage and stability
View Source - Frontiers in Bioengineering & Biotechnology — IGF-1: a promising therapeutic target for peripheral nerve injury
View Source
Educational and laboratory research information only. AllPeptides.eu does not sell peptides and does not provide medical advice or human-use instructions.